Last update:
Oncology & Cancer news
Oncology & Cancer
BRCA2 research reveals a novel mechanism behind chemoresistance
One of the biggest challenges in cancer treatment is chemoresistance: Tumors that initially respond well to chemotherapy become resistant over time. When that happens, treatment options are often limited.
7 hours ago
0
0
Oncology & Cancer
Americans have widespread misbeliefs about the cancer risks of alcohol, study finds
Despite clear evidence linking alcohol use to increased cancer risks, public awareness of this connection remains low in the U.S., according to new research from The University of Texas MD Anderson Cancer Center. Researchers ...
16 hours ago
1
38
Early clinical trial tests immune-boosting therapy before prostate cancer surgery
A small, early clinical trial led by the Icahn School of Medicine at Mount Sinai and collaborators has shown that directly injecting an immune-activating compound into prostate tumors before surgery appears safe and may help ...
11 hours ago
0
0
Experimental cancer drug shows exceptional tumor-fighting potential
A research team has developed a new chemotherapeutic agent, LiPyDau, which shows remarkable efficacy against multiple tumor types in preclinical studies. Published in the journal Molecular Cancer, the study introduces a highly ...
13 hours ago
0
0
FDA approves Blenrep for relapsed or refractory multiple myeloma
The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.
8 hours ago
0
0
Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target
Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and most comprehensive molecular analysis of renal medullary carcinoma (RMC), a rare and aggressive ...
13 hours ago
0
0
Breast cancer risk varies between different hormonal contraceptives, research reveals
Some common hormonal contraceptives are linked to a slightly higher risk of breast cancer than others. This is shown by a Swedish study from Uppsala University, in which researchers followed more than two million women and ...
17 hours ago
0
1
Safeguarding fertility: Study investigates key hormone for women with cancer choosing fertility preservation
Newly diagnosed female cancer patients of reproductive age have a very short window for storing their eggs and embryos before starting cancer treatment. This is a process known as fertility preservation (FP), which protects ...
12 hours ago
0
0
A promising molecule against chemotherapy-induced neuropathies
Currently incurable, peripheral neuropathies are common neurological complications of chemotherapy, causing persistent pain, tingling and burning sensations in the feet and hands, sometimes even after treatment has ended. ...
14 hours ago
0
0
From antibiotics to antimalarials: How repurposed drugs might keep cancer from returning
Many cancer survivors live with the worry that their cancer might come back. This "recurrence" occurs when cancer cells hide somewhere in the body—like in the bone marrow—and start growing again, sometimes years later. ...
18 hours ago
0
0
Mutation yields hot new clues for treating immune 'cold' tumors
Immune checkpoint inhibitors (ICIs) emerged in the US about 15 years ago as an exciting class of cancer treatments that have achieved complete and durable remissions for thousands of people with end-stage metastatic cancers. ...
Oct 29, 2025
0
2
Capturing cancer cells from blood could help doctors choose the right breast cancer treatment
Doctors may be able to spare patients unnecessarily aggressive breast cancer treatments by collecting and testing cancer cells in patients' blood, research from the University of Michigan and the University of Kansas suggests.
Oct 29, 2025
0
28
New technology restores chemotherapy effectiveness against resistant cancer cells
Scientists from King's College London have successfully applied a new technology that disarms one of the most potent weapons cancer cells use to weaken the effects of chemotherapy drugs.
Oct 29, 2025
0
11
Online tool identifies and ranks community factors that predict cancer disparities
A new study published in JAMA Network Open by the Harvey L. Neiman Health Policy Institute reveals poverty, environmental risks, housing issues, and physical inactivity are top-ranking community-level predictors of disparities ...
Oct 29, 2025
0
16
Implantable 'CANDI' wafer shows promise for preventing glioblastoma recurrence
Glioblastoma is an aggressive brain cancer that almost always recurs after surgery and radiochemotherapy. Now, researchers have developed a biodegradable implant that can be placed directly into the brain cavity after tumor ...
Oct 29, 2025
0
24
Enhancing the body's 'first responder' cells may boost immune therapy for cancer
Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard immunotherapies for cancer. Two research teams, working collaboratively but using distinct approaches, found ...
Oct 29, 2025
0
0
Demographic disparities found in uptake of colorectal cancer screenings
Colorectal cancer (CRC) screening is considered one of the most effective and successful tools to protect public health: Screening has been found to significantly reduce the incidence of CRC through the removal of precancerous ...
Oct 29, 2025
0
0
Challenging conventional wisdom on a common cause of melanoma
University of Queensland researchers have found that a genetic mutation that causes melanoma can lie dormant in healthy skin, a finding that could improve screening of areas more prone to the disease.
Oct 29, 2025
0
0
Additional testing of FISH-negative tests for renal cell carcinoma can improve kidney cancer diagnosis
A study from the University of Michigan Health Rogel Cancer Center and Department of Pathology shows that further testing in renal cell carcinoma with an overexpression of gene TRIM63 could uncover a mutation otherwise undetected, ...
Oct 29, 2025
0
0
Why are so many millennials getting cancer?
If you're reading this, there's a good chance that you, like me, are a millennial. If so, you've probably noticed more and more cases of friends or acquaintances with diseases that you would normally associate with later ...
Oct 29, 2025
0
0
Radiation therapy for patients with breast cancer
Radiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells and reduce the risk of the cancer recurring.
Oct 29, 2025
0
0
Discovery of breast cancer treatment resistance mechanism could lead to new hope for some
Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets ...
Oct 28, 2025
0
39
Drugs approved for treating pain may also reduce bone cancer growth
Peripheral afferent neurons—nerves that send signals from all areas of the body to the central nervous system (brain and spinal cord)—are known to infiltrate and grow within malignant bone tumors called osteosarcomas, ...
Oct 28, 2025
0
28
Custom-designed protein receptors help T cells target solid tumors more effectively
Cancer immunotherapy, especially using T cells, is showing a lot of promise in treating blood cancers. Bioengineered T cells, especially those equipped with chimeric antigen receptors (CAR-T cells), have revolutionized cancer ...
Oct 28, 2025
0
17
Protecting the gut after stem cell transplantation: New evidence uncovered for potential of microbiome-based therapies
Patients receiving intensive cancer treatments—such as radiation or stem cell transplantation—often suffer from severe damage to the intestinal lining. This not only causes pain and complications but also worsens long-term ...
Oct 28, 2025
0
1
